Skip to content

Released Feb 26, 2025, after the close

10-K filed Feb 26, 2025, 57 days after period end · 0001636422-25-000028

Q4 2024 · 10-K

derived · Computed from the longer spans the company filed.

Revenue$79.61Mderived+6.0% vs Q4 2023+4.3% vs Q3 2024
Net Income-$20.67MderivedN/M vs Q4 2023N/M vs Q3 2024
EPS, diluted—Not derived. Share counts vary by quarter.
Operating Incomederived-$17,500,000N/M
Operating Cash Flowderived-$3,527,000N/M
Free Cash Flowderived-$3,940,000N/M
Margins · derived
Operating margin-22.0%+21.7 pt vs Q4 2023
Net margin-26.0%+14.4 pt vs Q4 2023

What the release said

The release

Same quarter

MetricQ4 2024derived from reported figuresQ4 2023derived from reported figuresQ4 2022derived from reported figuresQ4 2021derived from reported figures
Revenue$79.61M$75.08M$69.16M$64.72M
Net Income-$20.67M-$30.31M-$35.78M-$48.99M

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Health Catalyst, Inc. · CIK 1636422 · Engraved from SEC EDGAR